LPL Financial
JUNO

LPL Financial’s Juno Therapeutics, Inc. JUNO Stock Holding History

LPL Financial’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-5,950
Closed -$235K – 3165
2016
Q1 		$235K Sell
5,950
-80
-1% -$2.79K ﹤0.01% 2692
2015
Q4 		$256K Buy
+6,030
New +$299K ﹤0.01% 2655
2015
Q3 		– Sell
-5,550
Closed -$302K – 2948
2015
Q2 		$302K Buy
+5,550
New +$295K ﹤0.01% 2301

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RCM
Riverhead Capital Management Wilmington, Delaware $2.71B AUM 2.34% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial's JUNO Position: Q2 2016 in Review

LPL Financial sold out of Juno Therapeutics, Inc. (JUNO) in Q2 2016, closing a stake of 5,950 shares — an estimated $235K sold.

LPL Financial first reported a position in JUNO in Q2 2015 and held it in 3 quarters. The position peaked at $302K in Q2 2015. 170 funds tracked by Wall St. Rank hold JUNO as of Q2 2016.

  • LPL Financial reported no remaining Juno Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • LPL Financial sold 5,950 Juno Therapeutics, Inc. shares in Q2 2016, an estimated $235K.
  • LPL Financial first reported a position in Juno Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • LPL Financial's Juno Therapeutics, Inc. position peaked at $302K in Q2 2015.
  • 170 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q2 2016.

Based on LPL Financial's 13F filing for Q2 2016, filed 15 Aug 2016.